# Standard BioTools Inc. (LAB) cash on hand history

URL: https://funkfolio.com/stock/LAB/cash

> Standard BioTools Inc. (LAB) cash on hand was $187.58M at the end of fiscal 2025, down 36.0% from fiscal 2024. Year-by-year chart and table.

---

## Standard BioTools Inc. (LAB) cash on hand

**Cash · fiscal 2025:** $187.58M at Dec 31, 2025

Standard BioTools Inc. (LAB) held cash of $187.58M at the end of fiscal 2025 (December 31, 2025). That is 36.0% lower than the $292.87M of fiscal 2024. Figures as of 18 Nov 2026, 01:00 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Cash, fiscal 2025:** $187.58M
- **Change on fiscal 2024:** −36.0%
- **Highest on record:** $292.87M fiscal 2024
- **Lowest on record:** $114.90M fiscal 2023
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 01:00 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Standard BioTools Inc. cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $292.87M in fiscal 2024 and the lowest $114.90M in fiscal 2023.

### Cash by fiscal year

### Standard BioTools Inc. cash on hand, year by year

Standard BioTools Inc. (LAB) cash on hand by fiscal year

| Fiscal year | Cash | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $187.58M | 36.0% down | Dec 31, 2025 |
| 2024 | $292.87M | 154.9% up | Dec 31, 2024 |
| 2023 | $114.90M | 30.7% down | Dec 31, 2023 |
| 2022 | $165.78M | — | Dec 31, 2022 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

### How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

### Standard BioTools Inc., figure by figure

- [Standard BioTools Inc. market cap](https://funkfolio.com/stock/LAB/market-cap)
- [Standard BioTools Inc. revenue](https://funkfolio.com/stock/LAB/revenue)
- [Standard BioTools Inc. earnings](https://funkfolio.com/stock/LAB/earnings)
- [Standard BioTools Inc. earnings per share (EPS)](https://funkfolio.com/stock/LAB/eps)
- [Standard BioTools Inc. P/E ratio](https://funkfolio.com/stock/LAB/pe-ratio)
- [Standard BioTools Inc. P/S ratio](https://funkfolio.com/stock/LAB/ps-ratio)
- [Standard BioTools Inc. P/B ratio](https://funkfolio.com/stock/LAB/pb-ratio)
- [Standard BioTools Inc. free cash flow](https://funkfolio.com/stock/LAB/free-cash-flow)
- [Standard BioTools Inc. operating margin](https://funkfolio.com/stock/LAB/operating-margin)
- [Standard BioTools Inc. dividend](https://funkfolio.com/stock/LAB/dividend)
- [Standard BioTools Inc. shares outstanding](https://funkfolio.com/stock/LAB/shares-outstanding)
- [Standard BioTools Inc. total debt](https://funkfolio.com/stock/LAB/total-debt)
- [Standard BioTools Inc. total assets](https://funkfolio.com/stock/LAB/total-assets)
- [Standard BioTools Inc. return on equity (ROE)](https://funkfolio.com/stock/LAB/roe)
- [Standard BioTools Inc. return on invested capital (ROIC)](https://funkfolio.com/stock/LAB/roic)

[Standard BioTools Inc. (LAB) overview: price, valuation and scorecard](https://funkfolio.com/stock/LAB)

### Standard BioTools Inc. cash on hand: questions and answers

**How much cash does Standard BioTools Inc. have?**

Standard BioTools Inc. (LAB) held cash of $187.58M at the end of fiscal 2025 (December 31, 2025). That is 36.0% lower than the $292.87M of fiscal 2024.

**What are the highest and lowest cash figures on record for Standard BioTools Inc.?**

Across the 4 fiscal years on record (2022–2025), the highest was $292.87M in fiscal 2024 and the lowest $114.90M in fiscal 2023.

**How is Standard BioTools Inc.'s cash calculated?**

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

Fiscal years are named for the calendar year they end in.

### Learn: cash on hand

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Standard BioTools Inc. (LAB) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/LAB/cash

Underlying data: the company's filings with the SEC and Yahoo Finance.
